Diltiazem Hydrochloride Protects Against Myocardial Ischemia/Reperfusion Injury in a BNIP3L/NIX-Mediated Mitophagy Manner
Xing Zhou,Quan Lu,Qiu Wang,Wenxin Chu,Jianhao Huang,Jinming Yu,Yuechou Nong,Wensheng Lu
DOI: https://doi.org/10.2147/jir.s493037
IF: 4.5
2024-11-23
Journal of Inflammation Research
Abstract:Xing Zhou, 1, &ast Quan Lu, 2, &ast Qiu Wang, 2, &ast Wenxin Chu, 2 Jianhao Huang, 2 Jinming Yu, 2 Yuechou Nong, 2 Wensheng Lu 2, &ast 1 Pharmacy Department, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China; 2 Department of Endocrinology and Metabolism, National Key Endocrine Clinical Construction Specialty, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wensheng Lu; Yuechou Nong, Department of Endocrinology and Metabolism, National Key Endocrine Clinical Construction Specialty, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, No. 6, Taoyuan Road, Nanning, Guangxi, 530021, People's Republic of China, Email ; ; Background: Mitochondrial calcium uptake-induced mitophagy may play an essential role in myocardial ischemia/reperfusion (MI/R) injury. Diltiazem hydrochloride (DIL), a traditional calcium channel blocker, can alleviate MI/R injury by blocking calcium overload. However, whether the protective mechanism of DIL involves mitophagy remains elusive. This study aimed to clarify the underlying molecular mechanism by which DIL ameliorates MI/R injury by downregulating mitophagy in vivo and in vitro. Methods: Thirty rats were randomized into three groups: the sham, MI/R, and MI/R+DIL (1 mg/kg) groups (n = 10/per group). MI/R injury was induced by ligating the left anterior descending (LAD) artery for 30 min followed by 60 min of reperfusion in vivo. H9C2 cells were selected to establish an oxygen-glucose deprivation/recovery (OGD/R) model to simulate MI/R injury in vitro. The potential mechanism by which DIL alleviates MI/R injury was analyzed based on tissue morphology, mitophagy-related gene transcription, and protein expression. Results: According to histological and immunohistochemical evaluations, DIL significantly alleviated myocardial damage in vivo. Moreover, DIL significantly increased cell viability, attenuated OGD/R-induced apoptosis, and inhibited mitochondrial autophagy in vitro. Mechanistically, DIL attenuated mitochondrial autophagy through the upregulation of dual-specificity protein phosphatase 1 (DUSP1) and the downregulation of c-Jun N-terminal kinase (JNK) and Bcl2 interacting protein 3-like (BNIP3L, also known as NIX) expression. Conclusion: Diltiazem hydrochloride protects against myocardial ischemia/reperfusion injury in a BNIP3L/NIX-mediated mitophagy manner in vivo and in vitro. Keywords: diltiazem hydrochloride, calcium channel blockers, myocardial infarction, myocardial ischemia/reperfusion injury, mitophagy The coronary atherosclerotic heart disease is the most common fatal cardiovascular disorder, and acute myocardial infarction (AMI) is a major cause of cardiovascular death. 1,2 Rapid restoration of myocardial perfusion after AMI is crucial for maintaining cardiac function; however, reperfusion acts as a double-edged sword which may aggravate myocardial injury, termed myocardial ischemia/reperfusion (MI/R) injury. 3 In recent years, researchers have conducted in-depth explorations of this phenomenon. Heusch et al, 4 Moens et al, 5 and He et al 6 have detailed the various pathophysiological mechanisms that occur during myocardial ischemia-reperfusion, including oxidative stress, inflammatory responses, apoptosis, and mitochondrial dysfunction. Although Bai et al 7 have provided a systematic review of the research on myocardial ischemia-reperfusion injury, the exact mechanisms of MI/R injury have not yet been fully elucidated and deserve further exploration. Cardiomyocyte death, mainly triggered by a serious shortage of adenosine triphosphate (ATP), is the fundamental pathological outcome of MI/R injury. 8 Mitochondrial oxidative phosphorylation is the major source of ATP in cardiac myocytes. 9 Thus, mitochondrial dysfunction plays a key role in MI/R injury 10,11 Mitochondrial autophagy, also known as "mitophagy", a form of selective mitochondrial autophagy, was first reported in 2005 12 and effectively ensures mitochondrial quality and cell survival. 13,14 Recent studies have revealed that basal mitophagy can effectively eliminate damaged or dysfunctional mitochondria and maintain cellular homeostasis, 15,16 while excessive mitophagy may lead to a low mitochondrial mass, insufficient energy production, and ex -Abstract Truncated-
immunology